STEPHANIE KEESEE: Open Payments
NPI 1699150052 · HOLDENVILLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 22 payments from 5 companies in 2025. Trend: 2023 $436 · 2024 $122 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $189 |
| Corcept Therapeutics | 3 | $93 |
| ABBVIE INC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, Korlym, ABILIFY ASIMTUFII, ABILIFY MAINTENA, VRAYLAR, QULIPTA, Saxenda, ZEPBOUND.
Industry payments across OK — which companies pay providers there.
